35 results
424B5
BTAI
BioXcel Therapeutics Inc
25 Mar 24
Prospectus supplement for primary offering
4:01pm
or preventing a change in control of our Company.
Classified Board of Directors
Our charter provides that our Board is divided into three classes
424B5
BTAI
BioXcel Therapeutics Inc
8 Feb 24
Prospectus supplement for primary offering
5:27pm
to certain exceptions. The statute could have the effect of delaying, deferring or preventing a change in control of our Company.
Classified Board
424B5
1b3d 19q11ae9twgp8u
14 Nov 23
Prospectus supplement for primary offering
8:57am
8-K
EX-99.1
w6a8dskt
10 Oct 23
Regulation FD Disclosure
7:06am
POS AM
722trhi1
11 Mar 22
Prospectus update (post-effective amendment)
9:26am
POSASR
w904e9i
10 Mar 22
Automatic shelf registration (post-effective amendment)
7:14pm